Workflow
IDEX(IEX) - 2025 Q1 - Quarterly Report
IEXIDEX(IEX)2025-05-01 20:34

Financial Performance - Net sales for Q1 2025 were 814.3million,a1.0814.3 million, a 1.0% increase from 800.5 million in Q1 2024[15] - Gross profit for Q1 2025 was 368.9million,upfrom368.9 million, up from 357.4 million in Q1 2024, reflecting a gross margin improvement[15] - Operating income decreased to 142.0millioninQ12025from142.0 million in Q1 2025 from 161.2 million in Q1 2024, a decline of 11.1%[15] - Net income attributable to IDEX for Q1 2025 was 95.5million,down21.495.5 million, down 21.4% from 121.4 million in Q1 2024[15] - Basic earnings per share for Q1 2025 were 1.26,comparedto1.26, compared to 1.60 in Q1 2024, a decrease of 21.3%[15] - The company reported a comprehensive income of 149.2millionforQ12025,significantlyhigherthan149.2 million for Q1 2025, significantly higher than 57.0 million in Q1 2024[16] - The Adjusted EBITDA for the total segments was 236.9millionforthethreemonthsendedMarch31,2025,slightlydownfrom236.9 million for the three months ended March 31, 2025, slightly down from 238.2 million in the same period of 2024[39] - Diluted EPS for Q1 2025 was 1.26,down211.26, down 21% from 1.60 in Q1 2024, while adjusted diluted EPS decreased by 7% to 1.75[95][96]ReportednetincomeforQ12025was1.75[95][96] - Reported net income for Q1 2025 was 95.4 million, down from 121.3millioninQ12024,representingadecreaseof21.5121.3 million in Q1 2024, representing a decrease of 21.5%[140] - Net income margin decreased to 11.7% in Q1 2025 from 15.2% in Q1 2024[140] - Adjusted EBITDA margin also saw a decline to 25.5% in Q1 2025 from 26.0% in Q1 2024[140] Assets and Liabilities - Total assets increased to 6,795.1 million as of March 31, 2025, compared to 6,745.3millionatDecember31,2024[19]Cashandcashequivalentsdecreasedto6,745.3 million at December 31, 2024[19] - Cash and cash equivalents decreased to 594.1 million from 620.8millionattheendof2024[19]TotalborrowingsasofMarch31,2025,amountedto620.8 million at the end of 2024[19] - Total borrowings as of March 31, 2025, amounted to 1,950.4 million, a decrease from 1,971.3millionasofDecember31,2024[55]ThefairvalueoftotalborrowingsasofMarch31,2025,was1,971.3 million as of December 31, 2024[55] - The fair value of total borrowings as of March 31, 2025, was 1,846.5 million, compared to a carrying amount of 1,949.2million[62]Thecompanyhad1,949.2 million[62] - The company had 249.0 million outstanding under its Revolving Facility, with a net available borrowing capacity of approximately 548.0 million[55] Segment Performance - The Fluid & Metering Technologies segment generated net sales of 290.5 million in Q1 2025, down from 313.7millioninQ12024,reflectingadecreaseof7.1313.7 million in Q1 2024, reflecting a decrease of 7.1%[37] - The Health & Science Technologies segment reported net sales of 341.5 million in Q1 2025, an increase from 310.1millioninQ12024,markingagrowthof10.5310.1 million in Q1 2024, marking a growth of 10.5%[37] - The Fire & Safety/Diversified Products segment achieved a 4% increase in net sales to 184.3 million, driven by targeted growth initiatives[111][113] Cash Flow and Investments - Net cash flows provided by operating activities for Q1 2025 were 105.7million,downfrom105.7 million, down from 156.6 million in Q1 2024[23] - Cash flows from operating activities decreased by 50.9millionto50.9 million to 105.7 million for the three months ended March 31, 2025, mainly due to increased investments in working capital[120] - Free cash flow for the three months ended March 31, 2025, was 91.4million,downfrom91.4 million, down from 136.6 million in the prior year[124] Shareholder Returns - Total dividend payments to common shareholders increased to 52.4millioninQ12025,comparedto52.4 million in Q1 2025, compared to 48.5 million in Q1 2024[128] - The company repurchased 0.3 million shares at a cost of 50.0millionduringthethreemonthsendedMarch31,2025[127]Thecompanyrepurchased0.3millionsharesatacostof50.0 million during the three months ended March 31, 2025[127] - The company repurchased 0.3 million shares at a cost of 50.4 million during Q1 2025, leaving 489.7millionremaininginsharerepurchaseauthorization[72]ExpensesandCostsSelling,generalandadministrativeexpensesincreasedby7489.7 million remaining in share repurchase authorization[72] Expenses and Costs - Selling, general and administrative expenses increased by 7% to 209.4 million, primarily due to acquisition-related costs[97][100] - Restructuring expenses surged to 17.5million,comparedto17.5 million, compared to 1.1 million in the same period last year, reflecting higher severance costs[97][101] - Acquisition-related costs incurred during the three months ended March 31, 2025, were 0.7million,comparedto0.7 million, compared to 1.3 million in the same period of 2024[34] Tax and Legal Matters - The effective tax rate for the three months ended March 31, 2025, was 23.4%, compared to 21.5% for the same period in 2024[89] - The company is involved in ongoing legal proceedings related to asbestos claims, but does not expect these to have a material adverse effect on its financial position[148] Market and Economic Conditions - The company expects to mitigate potential unfavorable impacts from tariffs and global trade policy changes through price increases and cost reductions[94] - Organic sales for the three months ended March 31, 2025, decreased by 1% compared to the prior year, primarily due to lower volumes in the semiconductor, automotive, and industrial sectors[115] Miscellaneous - The company maintained an interest coverage ratio of 14.08 to 1 and a leverage ratio of 2.22 to 1 as of March 31, 2025, in compliance with financial covenants[129] - There were no material changes in market risks or risk factors compared to the previous fiscal year[141][149] - The company's disclosure controls and procedures were deemed effective as of March 31, 2025[143]